SCHEMBL20797487

SCHEMBL20797487

CCN(c1ccc(C=O)cn1)C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
ALDH1A3 P47895 2/20 0.40
ALDH3A1 P30838 1/20 0.40
KDM4E B2RXH2 2/20 0.35
KCNJ1 P48048 1/20 0.35
CYP2A6 P11509 2/20 0.34
CYP2A13 Q16696 1/20 0.34
S1PR1 P21453 1/20 0.34
JAK2 O60674 2/20 0.34
JAK3 P52333 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
GBA1 P04062 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GPR119 Q8TDV5 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19330155 0.76 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL30369918 0.76 ALDH1A1 (0.57) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL29952831 0.75 ALDH1A1 (0.46) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL30592797 0.72 KCNH2 (0.51) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL934755 0.72 KCNH2 (0.51) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL28824869 0.72 S1PR1 (0.39) ALDH1A1S1PR1JAK2JAK3SMN1; SMN2
SCHEMBL18694469 0.72 LMNA (0.50) ALDH1A1KDM4EJAK2SMN1; SMN2LMNA
SCHEMBL20797725 0.71 ALDH1A1 (0.42) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL20797769 0.71 ALDH3A1 (0.50) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1
SCHEMBL20797695 0.70 HCAR3 (0.57) ALDH1A1ALDH1A3ALDH3A1KDM4EKCNJ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 WO disclosed
WO-2019049061-A1 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-03-14 WO disclosed